Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program

J Cyst Fibros. 2011 May;10(3):207-11. doi: 10.1016/j.jcf.2011.02.006. Epub 2011 Mar 22.

Abstract

Background: In Sardinia the mutational spectrum of CFTR gene is well defined. A mutation detection rate of 94% can be achieved by screening for 15 CFTR mutations with a frequency higher than 0.5%. The efficiency of this molecular test suggests that Sardinians may represent a suitable population for a preconceptional screening.

Methods: Five hundred couples of Sardinia descent were screened for 38 mutations using a semi-automated reverse-dot blot and PCR-gel electrophoresis assays. This mutation panel included the 15 most frequent CF alleles in Sardinia.

Results: We identified 38 CF carriers, revealing an overall frequency of 1/25 (4%). The most common CF allele was the p.Thr338Ile (T338I) (65%), followed by the p.Phe508del (F508del) (22.5%). We also identified one couple at risk and an asymptomatic female homozygote for the p.Thr338Ile allele.

Conclusions: In spite of the low number of the couples tested, the results herein reported demonstrate the efficacy and efficiency of the preconceptional screening program and the high participation rate of the Sardinian population (99%).

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cystic Fibrosis / genetics*
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics*
  • Female
  • Gene Deletion
  • Gene Frequency
  • Genetic Carrier Screening*
  • Genetic Predisposition to Disease
  • Genetic Testing / standards*
  • Homozygote
  • Humans
  • Isoleucine
  • Italy
  • Male
  • Mutation*
  • Phenylalanine
  • Pilot Projects
  • Threonine

Substances

  • Isoleucine
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Threonine
  • Phenylalanine